Post-transplantation encapsulating peritoneal sclerosis in a pediatric patient

Pediatric Nephrology

Volumn 27, Issue 9, 2012, Pages 1583-1588

  Da Silva, Nicole ^a   Rocha, Sofia ^a   Rocha, Liliana ^a   Faria, Sameiro ^a   Costa, Teresa ^a   Mota, Conceiçao ^a  

^a HOSPITAL MARIA PIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CYCLOSPORIN; MERCAPTAMINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; STEROID; TACROLIMUS; TAMOXIFEN; THYMOCYTE ANTIBODY; UREA;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ACUTE APPENDICITIS; ACUTE GRAFT REJECTION; ADOLESCENT; APPENDIX DISEASE; ARTERIOVENOUS FISTULA; ARTICLE; CASE REPORT; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; CREATININE BLOOD LEVEL; CYSTINOSIS; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FANCONI RENOTUBULAR SYNDROME; FEMALE; HEMODIALYSIS; HUMAN; INTESTINE OBSTRUCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LAPAROTOMY; LIVER TOXICITY; NUTRITIONAL SUPPORT; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONITIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TOTAL PARENTERAL NUTRITION; UREA BLOOD LEVEL; VOMITING;

ADOLESCENT; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; POSTOPERATIVE COMPLICATIONS; PREDNISOLONE; SIROLIMUS; TACROLIMUS;

EID: 84864419946     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-012-2176-y     Document Type: Article

References (39)

1. Gandhi VC, Humayan HM, Ing TS, Daugirdas JT, Jablokow VR, Iwatsuki S, Geis WP, Hano JE (1980) Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 140:1201-1203 (Pubitemid 10048816)
2. Ekim M, Fitöz S, Yagmurlu A, Ensari A, Yüksel S, Acar B, Ozçakar ZB, Kendirli T, Bingöler B, Yalçinkaya F (2005) Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients. Nephrology 10:341-343 (Pubitemid 41725507)
3. Kawanishi H, Moriishi M, Ide K, Dohi K (2008) Recommendation of the surgical option for treatment of encapsulating peritoneal sclerosis. Perit Dial Int 28:S205-S210
4. George C, Al-Zwae K, Nair S, Cast JE (2007) Computed tomography appearances of sclerosing encapsulating peritonitis. Clin Radiol 62:732-737 (Pubitemid 46971643)
5. Garces-Inigo EF, Lee EY (2008) Sclerosing encapsulating peritonitis. Pediatr Radiol 38:245
6. Korte MR, Habib SM, Lingsma H, Weimar W, Betjes MG (2011) Post transplantation encapsulating peritoneal sclerosis contributes significantly to mortality after kidney transplantation. Am J Transplant 3:599-605
7. Korte MR, Fieren MW, Sampimon DE, Lingsma HF, Weimar W, Betjes MG, Investigators of the Dutch Multicentre EPS Study (2011) Tamoxifen is associated with lower mortality of encapsulating peritonitis sclerosis: results of the Dutch Multicenter EPS study. Nephrol Dial Transplant 26:691-697
8. Araki Y, Hataya H, Tanaka Y, Fukuzawa R, Ikeda M, Kawamura K, Honda M(2000) Long-term peritoneal dialysis is a risk factor of sclerosing encapsulating peritonitis in children. Perit Dial Int 20:445-451
9. Hoshii S, Honda M, Itami N, Oh S, Matsumura C, Moriya S, Mori M, Hatae K, Ito Y, Karashima S (2000) Sclerosing encapsulating peritonitis in pediatric peritoneal dialysis patients. Pediatr Nephrol 14:275-279 (Pubitemid 30166706)
10. Warady BA (2000) Sclerosing encapsulating peritonitis: what approach should be taken with children? Perit Dial Int 20:390-391
11. Tan FLS, Loh D, Prabhakaran K (2005) Sclerosing encapsulating peritonitis in a child secondary to peritoneal dialysis. J Pediatr Surg 40:E21-E23 (Pubitemid 40724884)
12. Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa K (1996) Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis 28:420-427 (Pubitemid 26304423)
13. Hoshii S, Honda M (2002) The study group of pediatric PD conference in Japan: High incidence of encapsulating peritoneal sclerosis in pediatric patients on peritoneal dialysis longer than 10 years. Perit Dial Int 22:730-731 (Pubitemid 36131508)
14. Rigby RJ, Hawley CM (1998) Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant 13:154-159 (Pubitemid 28033596)
15. Nakamoto H, Kawaguchi Y, Suzuki H (2002) Encapsulating peritoneal sclerosis in patients undergoing continuos ambulatory peritoneal dialysis in Japan. Adv Perit Dial 18:119-123
16. Kawanishi H, Kawaguchi Y (2000) Prevalence and therapeutic outcome of s sclerosing encapsulating peritonitis (EPS)-A multicenter study in Japan. Jin To Toseki 49:225-228
17. Kawanishi H, Kawaguchi Y, Fukui H, Hara S, Imada A, Kubo H, Kin M, Nakamoto M, Ohira S, Shoji T (2004) Encapsulating peritoneal sclerosis in Japan: a prospective, controlled multicenter study. Am J Kidney Dis 44:729-737 (Pubitemid 39237618)
18. Honda M, Bradley A, Warady A (2010) Long-term peritoneal dialysis and encapsulating peritoneal sclerosis in children. Pediatr Nephrol 25:75-81
19. Brown MC, Simpson K, Kerssens JJ, Mactier RA, Registry SR (2009) Encapsulating peritoneal sclerosis in the new millennium: a national cohort study. Clin J Am Soc Nephrol 4:1222-1229
20. Tan R, Betjes M, Cransberg K (2011) Post-transplantation encapsulating peritoneal sclerosis in a young child. Nephrol Dial Transplant 26:3822-3824
21. Moustafellos P,HadjianastassiouV, RoyD,Velzeboer NE, Maniakyn N, Vaidya A, Friend PJ (2006) Tamoxifen therapy in encapsulating sclerosing peritonitis in patients after kidney transplantation. Transplant Proc 38:2913-2914 (Pubitemid 44737977)
22. Santos L, Ramos A (2010) Encapsulating peritoneal sclerosis in patients on peritoneal dialysis. A single centre experience. Port J Nephrol Hypertens 24(1):57-61
23. Korte MR, Sampimon DE, Betjes MG, Krediet RT (2011) Encapsulating peritoneal sclerosis: the state of affairs. Nat Rev Nephrol 7:528-538
24. Evrenkaya TR, Atasoyu TM, Unver S, Basekim C, Baloglu H, Tulbek MY (2004) Corticosteroid and tamoxifen therapy in sclerosing encapsulating peritonitis in a patient on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 19:2423-2424 (Pubitemid 39214154)
25. Shihab FS, Bennett WM, Tanner AM, Andoh TF (1997) Mechanism of fibrosis in experimental tacrolimus nephrotoxicity. Transplantation 64:1829-1837 (Pubitemid 28041725)
26. Tarzi RM, Lim A, Moser S, Ahmad S, George A, Balasubramaniam G, Clutterbuck EJ, Gedroyc W, Brown EA (2009) Assessing the validity of an abdominal CT scoring system in the diagnosis of encapsulating peritoneal sclerosis. Clin J Am Soc Nephrol 3:1702-1710
27. Vlijm A, Stoker J, Bipat S, Spijkerboer AM, Phoa SS, Maes R, Struijk DG, Krediet RT (2009) Computed tomographic findings characteristic for encapsulating peritoneal sclerosis: a case control study. Perit Dial Int 29:517-522
28. Machado DJ, Cocuzza CS, Nahas WC, Ianhez LE (2000) Sclerosing encapsulating peritonitis after renal transplantation. Does it make sense? Perit Dial Int 20(3):341-343 (Pubitemid 30497174)
29. Shin G, Khanna A, Ding R, Sharma VK, Lagman M, Li B, Suthanthiran M (1998) In vivo expression of transforming growth factor-ß1 in humans-stimulation by cyclosporine. Transplantation 65:313-318 (Pubitemid 28095955)
30. Nakamoto H (2005) Encapsulating peritoneal sclerosis-A clinician's approach to diagnosis and medical management. Perit Dial Int 25(S4):S30-S38 (Pubitemid 41600357)
31. Moriishi M, Kawanishi H, Kawai T, Takahashi S, Hirai T, Shishida M, Watanabe H, Takahashi N (2002) Preservation of peritoneal catheter for prevention of encapsulating peritoneal sclerosis. Adv Perit Dial 18:149-153
32. Nakamoto H, Tranaeus A (2005) Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment and preventive measures. Perit Dial Int 25[suppl 4]:S83-S95 (Pubitemid 41600364)
33. Del Peso G, Bajo A, Gil F, Aguilera A, Ros S, Costero O, Jose Castro M, Selgas R (2003) Clinical experience with tamoxifen in peritoneal fibrosing syndromes. Adv Perit Dial 19:32-35
34. Eltoum MA, Wright S, Atchley J, Mason JC (2006) Four consecutive cases of peritoneal dialysis-related encapsulating peritoneal sclerosis treated successfully with tamoxifen. Perit Dial Int 26:203-206 (Pubitemid 44336172)
35. Summers Angela M, Clancy Marc J, Syed F, Harwood N, Brenchley PE, Augustine T, Riad H, Hutchison AJ, Taylor P, Pearson R, Gokal R (2005) Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal disease. Kidney Int 68:2381-2388 (Pubitemid 43117819)
36. Ahbeddou N, Belbaraka R, Fetohi M, Errihani H (2011) Tamoxifen-induced hepatotoxicity. Indian J Cancer 48:385
37. Temple S, Zaltzman J, Perl J (2010) Development of encapsulating peritoneal sclerosis in a renal transplant recipient on sirolimus immunotherapy. Perit Dial Int 30:475-476
38. Duman S, Bozkurt D, Sipahi S, Sezak M, Ozkan S, Ertilav M, Sen S, Ok E (2008) Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model. Adv Perit Dial 24:104-110
39. Rajani R, Smyth J, Koffman CG, Abbs I, Goldsmith DJ (2002) Differential effect of sirolimus vs prednisolone in the treatment of sclerosing encapsulating peritonitis. Nephrol Dial Transplant 17:2278-2280 (Pubitemid 35446697)